115 related articles for article (PubMed ID: 10993795)
1. Selegiline improves cardiac sympathetic terminal function and beta-adrenergic responsiveness in heart failure.
Shite J; Dong E; Kawai H; Stevens SY; Liang CS
Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H1283-90. PubMed ID: 10993795
[TBL] [Abstract][Full Text] [Related]
2. Alterations in cardiac adrenergic terminal function and beta-adrenoceptor density in pacing-induced heart failure.
Kawai H; Mohan A; Hagen J; Dong E; Armstrong J; Stevens SY; Liang CS
Am J Physiol Heart Circ Physiol; 2000 May; 278(5):H1708-16. PubMed ID: 10775152
[TBL] [Abstract][Full Text] [Related]
3. Selegiline attenuates cardiac oxidative stress and apoptosis in heart failure: association with improvement of cardiac function.
Qin F; Shite J; Mao W; Liang CS
Eur J Pharmacol; 2003 Feb; 461(2-3):149-58. PubMed ID: 12586210
[TBL] [Abstract][Full Text] [Related]
4. Cardiac sympathetic neuroprotective effect of desipramine in tachycardia-induced cardiomyopathy.
Liang CS; Mao W; Iwai C; Fukuoka S; Stevens SY
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H995-1003. PubMed ID: 16214845
[TBL] [Abstract][Full Text] [Related]
5. Alterations by norepinephrine of cardiac sympathetic nerve terminal function and myocardial beta-adrenergic receptor sensitivity in the ferret: normalization by antioxidant vitamins.
Liang C; Rounds NK; Dong E; Stevens SY; Shite J; Qin F
Circulation; 2000 Jul; 102(1):96-103. PubMed ID: 10880421
[TBL] [Abstract][Full Text] [Related]
6. Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF.
Liang CS; Himura Y; Kashiki M; Stevens SY
Am J Physiol Heart Circ Physiol; 2002 Nov; 283(5):H1863-72. PubMed ID: 12384464
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy.
Shite J; Qin F; Mao W; Kawai H; Stevens SY; Liang C
J Am Coll Cardiol; 2001 Nov; 38(6):1734-40. PubMed ID: 11704389
[TBL] [Abstract][Full Text] [Related]
8. Desipramine attenuates loss of cardiac sympathetic neurotransmitters produced by congestive heart failure and NE infusion.
Liang CS; Yatani A; Himura Y; Kashiki M; Stevens SY
Am J Physiol Heart Circ Physiol; 2003 May; 284(5):H1729-36. PubMed ID: 12543636
[TBL] [Abstract][Full Text] [Related]
9. The NADPH oxidase inhibitor apocynin improves cardiac sympathetic nerve terminal innervation and function in heart failure.
Wang K; Zhu ZF; Chi RF; Li Q; Yang ZJ; Jie X; Hu XL; Han XB; Wang JP; Li B; Qin FZ; Fan B
Exp Physiol; 2019 Nov; 104(11):1638-1649. PubMed ID: 31475749
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure.
Kawai H; Stevens SY; Liang CS
Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H3012-9. PubMed ID: 11087259
[TBL] [Abstract][Full Text] [Related]
11. Cardiac sympathetic neuronal function in left ventricular volume and pressure overload.
Somsen GA; Dubois EA; Brandsma K; de Jong J; van der Wouw PA; Batink HD; van Royen EA; Lie KI; van Zwieten PA
Cardiovasc Res; 1996 Jan; 31(1):132-8. PubMed ID: 8849597
[TBL] [Abstract][Full Text] [Related]
12. The effects of clonidine on arterial baroreflex sensitivity and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with left ventricular dysfunction.
Yuasa F; Kawamura A; Yokoe H; Yoshida S; Murakawa K; Sugiura T; Iwasaka T
Clin Physiol Funct Imaging; 2011 Mar; 31(2):94-100. PubMed ID: 20969725
[TBL] [Abstract][Full Text] [Related]
13. ACE inhibition improves cardiac NE uptake and attenuates sympathetic nerve terminal abnormalities in heart failure.
Kawai H; Fan TH; Dong E; Siddiqui RA; Yatani A; Stevens SY; Liang CS
Am J Physiol; 1999 Oct; 277(4):H1609-17. PubMed ID: 10516201
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic clonidine administration on sympathetic nerve traffic and baroreflex function in heart failure.
Grassi G; Turri C; Seravalle G; Bertinieri G; Pierini A; Mancia G
Hypertension; 2001 Aug; 38(2):286-91. PubMed ID: 11509491
[TBL] [Abstract][Full Text] [Related]
15. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure.
Himura Y; Felten SY; Kashiki M; Lewandowski TJ; Delehanty JM; Liang CS
Circulation; 1993 Sep; 88(3):1299-309. PubMed ID: 8102598
[TBL] [Abstract][Full Text] [Related]
16. Short-term effects of naloxone on hemodynamics and baroreflex function in conscious dogs with pacing-induced congestive heart failure.
Himura Y; Liang CS; Imai N; Delehanty JM; Woolf PD; Hood WB
J Am Coll Cardiol; 1994 Jan; 23(1):194-200. PubMed ID: 8277081
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II blockade [corrected] enhances baroreflex control of sympathetic outflow in heart failure.
Murakami H; Liu JL; Zucker IH
Hypertension; 1997 Feb; 29(2):564-9. PubMed ID: 9040439
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content.
Delehanty JM; Himura Y; Elam H; Hood WB; Liang CS
Am J Physiol; 1994 Mar; 266(3 Pt 2):H930-5. PubMed ID: 8160840
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Na+/H+-exchanger with sabiporide attenuates the downregulation and uncoupling of the myocardial beta-adrenoceptor system in failing rabbit hearts.
Leineweber K; Aker S; Beilfuss A; Rekasi H; Konietzka I; Martin C; Heusch G; Schulz R
Br J Pharmacol; 2006 May; 148(2):137-46. PubMed ID: 16520740
[TBL] [Abstract][Full Text] [Related]
20. Effects of beta-blockade on neurohumoral responses and neurochemical markers in pacing-induced heart failure.
Levett JM; Marinelli CC; Lund DD; Pardini BJ; Nader S; Scott BD; Augelli NV; Kerber RE; Schmid PG
Am J Physiol; 1994 Feb; 266(2 Pt 2):H468-75. PubMed ID: 8141347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
